JP2016214367A - Blood purification device - Google Patents

Blood purification device Download PDF

Info

Publication number
JP2016214367A
JP2016214367A JP2015100155A JP2015100155A JP2016214367A JP 2016214367 A JP2016214367 A JP 2016214367A JP 2015100155 A JP2015100155 A JP 2015100155A JP 2015100155 A JP2015100155 A JP 2015100155A JP 2016214367 A JP2016214367 A JP 2016214367A
Authority
JP
Japan
Prior art keywords
blood pressure
blood
pressure
pulse
predetermined threshold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015100155A
Other languages
Japanese (ja)
Other versions
JP6496606B2 (en
Inventor
仁 後藤
Hitoshi Goto
仁 後藤
村上 智也
Tomoya Murakami
智也 村上
将弘 豊田
Masahiro Toyoda
将弘 豊田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Priority to JP2015100155A priority Critical patent/JP6496606B2/en
Publication of JP2016214367A publication Critical patent/JP2016214367A/en
Application granted granted Critical
Publication of JP6496606B2 publication Critical patent/JP6496606B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • External Artificial Organs (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a blood purification device capable of notifying of an abnormality of a patient with a high degree of precision by effectively using parameters related to blood pressure.SOLUTION: A blood purification device equipped with treatment means 1 capable of purifying a patient's blood that extracorporeally circulates and performing blood purification treatment, and blood pressure detection means 2 for detecting blood pressure and a pulse of the patient undergoing blood purification treatment includes: calculation means 4 for obtaining at least pulse pressure, average blood pressure, and minimal blood pressure based on the value of detection by the blood pressure detection means 2; determination means 5 for determining whether or not the pulse pressure, average blood pressure, and minimal blood pressure obtained by the calculation means 4 have exceeded predetermined threshold values respectively; and display means 7 for performing predetermined notification according to the pulse pressure, minimal blood pressure, or average blood pressure on condition that it is determined by the determination means 5 that the pulse pressure, minimal blood pressure or average blood pressure has exceeded the predetermined threshold value.SELECTED DRAWING: Figure 1

Description

本発明は、体外循環する患者の血液を浄化して血液浄化治療を行い得る治療手段と、血液浄化治療中の患者の最高血圧、最低血圧及び脈拍を検出し得る血圧検出手段とを備えた血液浄化装置に関するものである。   The present invention relates to blood comprising therapeutic means capable of purifying blood of a patient circulating extracorporeally to perform blood purification treatment, and blood pressure detection means capable of detecting the maximum blood pressure, minimum blood pressure and pulse of the patient undergoing blood purification treatment. The present invention relates to a purification device.

一般に、透析治療においては、患者の血液を体外循環させるための血液回路と、該血液回路の途中に接続されたダイアライザと、しごき型の血液ポンプと、ダイアライザとの間で透析液の導入又は導出を行って血液透析処理を行いつつ除水可能な透析装置本体とを有した透析治療装置が用いられる。このような透析治療装置により行われる透析治療は、通常、1日おきに約4時間行われるものであるため、治療中の患者の血行動態が大きく変化することとなり、特に、余剰水分の除去(除水)による血圧低下防止を有効且つ確実に行うことは、重要な課題となっている。   In general, in dialysis treatment, a blood circuit for circulating a patient's blood extracorporeally, a dialyzer connected in the middle of the blood circuit, an iron-type blood pump, and a dialyzer are introduced or led out. A dialysis treatment apparatus having a dialysis apparatus main body that can be dehydrated while performing hemodialysis treatment is used. Since the dialysis treatment performed by such a dialysis treatment apparatus is usually performed for about 4 hours every other day, the hemodynamics of the patient under treatment changes greatly, and in particular, removal of excess water ( It is an important issue to effectively and surely prevent blood pressure reduction by water removal).

このような課題に対処すべく、従来、血液浄化治療中の患者の血圧を測定するための血圧計(血圧検出手段)を備えた透析治療装置が提案されている。かかる従来の透析治療装置によれば、血液浄化治療中の患者の血圧(特に、患者の最高血圧)を血圧計にて監視することができ、血圧低下を医師等医療従事者に把握させることができる(例えば、特許文献1〜3参照)。   In order to cope with such a problem, conventionally, a dialysis treatment apparatus including a sphygmomanometer (blood pressure detection means) for measuring the blood pressure of a patient during blood purification treatment has been proposed. According to such a conventional dialysis treatment apparatus, the blood pressure of the patient during blood purification treatment (especially the patient's maximum blood pressure) can be monitored with a sphygmomanometer, and a medical staff such as a doctor can grasp the decrease in blood pressure. (For example, refer to Patent Documents 1 to 3).

特開2010−104750号公報JP 2010-104750 A 特開平5−115546号公報Japanese Patent Laid-Open No. 5-115546 特表2004−527296号公報JP-T-2004-527296

しかしながら、上記従来技術においては、最高血圧を監視して血圧低下を報知させることができるものの、最低血圧や平均血圧等、血圧に関する他のパラメータを有効に活用できていないという問題があった。本出願人は、最高血圧以外の血圧に関するパラメータを有効活用することを鋭意検討し、特に、最高血圧と最低血圧との差から算出される脈圧、最低血圧及び平均血圧について監視することを検討した。すなわち、脈圧は、中枢の動脈硬化の指標として用いることができるとともに、最低血圧及び平均血圧は、冠動脈血流量の指標及び重要臓器の血流状態の指標としてそれぞれ用いることができるからである。   However, in the above-described conventional technology, although the maximum blood pressure can be monitored and the decrease in blood pressure can be notified, there is a problem that other parameters relating to the blood pressure such as the minimum blood pressure and the average blood pressure cannot be effectively used. The applicant has eagerly studied the effective use of parameters related to blood pressure other than the systolic blood pressure, and in particular, monitoring the pulse pressure, the diastolic blood pressure and the average blood pressure calculated from the difference between the systolic blood pressure and the diastolic blood pressure. did. That is, the pulse pressure can be used as an index of central arteriosclerosis, and the minimum blood pressure and the average blood pressure can be used as an index of coronary blood flow and an index of blood flow state of an important organ, respectively.

本発明は、このような事情に鑑みてなされたもので、血圧に関するパラメータを有効活用して患者の異常を精度よく報知することができる血液浄化装置を提供することにある。   The present invention has been made in view of such circumstances, and it is an object of the present invention to provide a blood purification apparatus capable of accurately reporting a patient's abnormality by effectively utilizing parameters related to blood pressure.

請求項1記載の発明は、体外循環する患者の血液を浄化して血液浄化治療を行い得る治療手段と、血液浄化治療中の患者の血圧及び脈拍を検出し得る血圧検出手段とを備えた血液浄化装置において、前記血圧検出手段による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求める算出手段と、該算出手段で求められた前記脈圧、平均血圧及び最低血圧がそれぞれ所定閾値を超えたか否か判定する判定手段と、該判定手段にて前記脈圧、最低血圧又は平均血圧が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧に応じた所定の報知を行わせる報知手段とを備えたことを特徴とする。   The invention according to claim 1 is a blood comprising treatment means capable of purifying blood of a patient circulating extracorporeally and performing blood purification treatment, and blood pressure detection means capable of detecting blood pressure and pulse of the patient undergoing blood purification treatment. In the purification device, based on the detection value by the blood pressure detection means, calculation means for obtaining at least pulse pressure, average blood pressure, and minimum blood pressure, and the pulse pressure, average blood pressure, and minimum blood pressure determined by the calculation means are respectively predetermined threshold values. Depending on the pulse pressure, minimum blood pressure, or average blood pressure, provided that the determination means determines that the pulse pressure, minimum blood pressure, or average blood pressure has exceeded a predetermined threshold. And a notification means for performing predetermined notification.

請求項2記載の発明は、請求項1記載の血液浄化装置において、前記脈圧が所定閾値を超え、且つ、前記最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで前記報知手段による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせることを特徴とする。   The invention according to claim 2 is the blood purification apparatus according to claim 1, wherein the pulse pressure exceeds a predetermined threshold, and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold, and the pulse pressure Is different from the second state in which at least one of the minimum blood pressure and the average blood pressure exceeds the predetermined threshold, and the notification state regarding the degree of danger by the notification means is different in the second state. It is characterized by notifying that the degree of danger is higher than the state of 1.

請求項3記載の発明は、請求項1又は請求項2記載の血液浄化装置において、前記算出手段は、前記脈圧、平均血圧及び最低血圧に加え、前記血圧検出手段による検出値に基づいて、最高血圧及び血液浄化治療開始からの最高血圧低下度を求めるものとされ、前記判定手段にて前記最高血圧及び最高血圧低下度が所定閾値を超えたか否か判定するとともに、前記報知手段にて前記最高血圧又は最高血圧低下度が所定閾値を超えたと判定されたことを条件として、当該最高血圧又は最高血圧低下度に応じた所定の報知を行わせることを特徴とする。   According to a third aspect of the present invention, in the blood purification apparatus according to the first or second aspect, the calculation means is based on a detection value by the blood pressure detection means in addition to the pulse pressure, the average blood pressure, and the minimum blood pressure. The maximum blood pressure and the maximum blood pressure decrease degree from the start of blood purification treatment are determined, and the determination means determines whether the maximum blood pressure and the maximum blood pressure decrease degree exceed a predetermined threshold, and the notification means On the condition that it is determined that the systolic blood pressure or the systolic blood pressure lowering level exceeds a predetermined threshold value, predetermined notification according to the systolic blood pressure or the systolic blood pressure lowering level is performed.

請求項4記載の発明は、請求項1〜3の何れか1つに記載の血液浄化装置において、前記算出手段は、前記脈圧、平均血圧及び最低血圧に加え、前記血圧検出手段による検出値に基づいて、脈拍数及び該脈拍数に最高血圧を乗算して求められるPRPを求めるものとされ、前記判定手段にて前記脈拍数及びPRPが所定閾値を超えたか否か判定するとともに、前記報知手段にて前記脈拍数又はPRPが所定閾値を超えたと判定されたことを条件として、当該脈拍数又はPRPに応じた所定の報知を行わせることを特徴とする。   Invention of Claim 4 is the blood purification apparatus as described in any one of Claims 1-3. WHEREIN: In addition to the said pulse pressure, average blood pressure, and the minimum blood pressure, the said calculation means is the detection value by the said blood pressure detection means. The pulse rate and the PRP obtained by multiplying the pulse rate by the maximum blood pressure are determined, and the determination means determines whether the pulse rate and the PRP exceed a predetermined threshold, and the notification On the condition that the pulse rate or PRP is determined to have exceeded a predetermined threshold by the means, predetermined notification according to the pulse rate or PRP is performed.

請求項5記載の発明は、請求項1〜4の何れか1つに記載の血液浄化装置において、前記報知手段は、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段から成り、当該表示手段によって、前記算出手段で求められた算出値と血液浄化治療中の循環血液量の変化率とが併せて表示されることを特徴とする。   According to a fifth aspect of the present invention, in the blood purification apparatus according to any one of the first to fourth aspects, the notification means includes display means capable of displaying information related to blood purification treatment in real time. By the means, the calculated value obtained by the calculating means and the rate of change of the circulating blood volume during the blood purification treatment are displayed together.

請求項6記載の発明は、請求項1〜5の何れか1つに記載の血液浄化装置において、血液浄化治療中の患者の心電図を測定し得る心電図用測定手段と、該心電図用測定手段からの測定信号に基づいて心電図を得る心電図取得手段とを具備するとともに、前記判定手段にて前記心電図取得手段で取得された心電図に異常があるか否かを判定するとともに、前記心電図に異常があると判定されたことを条件として、前記報知手段にて当該心電図の異常に応じた所定の報知を行わせることを特徴とする。   According to a sixth aspect of the present invention, in the blood purification apparatus according to any one of the first to fifth aspects, an electrocardiogram measuring unit capable of measuring an electrocardiogram of a patient undergoing blood purification treatment, and the electrocardiogram measuring unit And an electrocardiogram acquisition means for obtaining an electrocardiogram based on the measurement signal, and the determination means determines whether or not the electrocardiogram acquired by the electrocardiogram acquisition means is abnormal, and the electrocardiogram is abnormal On the condition that it is determined that the notification means performs a predetermined notification according to the abnormality of the electrocardiogram.

請求項7記載の発明は、請求項6記載の血液浄化装置において、前記心電図取得手段で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得る解析手段を具備するとともに、当該解析手段による心拍変動解析の結果に応じて前記判定手段による判定が行われることを特徴とする。   The invention according to claim 7 is the blood purification apparatus according to claim 6, further comprising an analysis unit capable of performing an analysis of heart rate variability based on the electrocardiogram acquired by the electrocardiogram acquisition unit and evaluating an autonomic nerve function, The determination by the determination unit is performed according to the result of the heart rate variability analysis by the analysis unit.

請求項8記載の発明は、請求項7記載の血液浄化装置において、前記心電図取得手段及び解析手段は、血液浄化治療中の患者の近傍に配設されたベッドサイド端末装置、又は血液浄化治療に関わる条件又は情報を送信し得る中央監視装置に配設されたことを特徴とする。   The invention according to claim 8 is the blood purification apparatus according to claim 7, wherein the electrocardiogram acquisition means and the analysis means are used for a bedside terminal device disposed in the vicinity of a patient undergoing blood purification treatment, or for blood purification treatment. It is arranged in a central monitoring device capable of transmitting the relevant conditions or information.

請求項9記載の発明は、請求項1〜8の何れか1つに記載の血液浄化装置において、前記報知手段は、前記算出手段で算出された算出値に基づいて推定される患者の状態を表示し得ることを特徴とする。   The invention according to claim 9 is the blood purification apparatus according to any one of claims 1 to 8, wherein the notifying means indicates the state of the patient estimated based on the calculated value calculated by the calculating means. It can be displayed.

請求項1の発明によれば、血圧検出手段による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求める算出手段と、算出手段で求められた脈圧、平均血圧及び最低血圧がそれぞれ所定閾値を超えたか否か判定する判定手段と、判定手段にて脈圧、最低血圧又は平均血圧が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧に応じた所定の報知を行わせる報知手段とを備えたので、血圧に関するパラメータを有効活用して患者の異常を精度よく報知することができる。   According to the first aspect of the present invention, the calculation means for obtaining at least the pulse pressure, the average blood pressure and the minimum blood pressure based on the detection value by the blood pressure detection means, and the pulse pressure, the average blood pressure and the minimum blood pressure obtained by the calculation means are respectively According to the determination means for determining whether or not the predetermined threshold is exceeded, and on the condition that the determination means determines that the pulse pressure, the minimum blood pressure or the average blood pressure has exceeded the predetermined threshold, according to the pulse pressure, the minimum blood pressure or the average blood pressure In addition, since the notification means for performing the predetermined notification is provided, it is possible to effectively notify the patient abnormality by effectively utilizing the parameters relating to the blood pressure.

請求項2の発明によれば、脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで報知手段による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせるので、危険度の重み付け(危険度の軽重付け)を行って報知することができる。   According to the invention of claim 2, the first state in which the pulse pressure exceeds the predetermined threshold and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold, the pulse pressure exceeds the predetermined threshold, and the minimum blood pressure and The notification form regarding the degree of risk by the notification means is different between the second state in which at least one of the average blood pressures exceeds a predetermined threshold, and a notification that the degree of risk is higher in the second state than in the first state. Since this is performed, it is possible to perform notification by weighting the risk level (weighting the risk level).

請求項3の発明によれば、算出手段は、脈圧、平均血圧及び最低血圧に加え、血圧検出手段による検出値に基づいて、最高血圧及び血液浄化治療開始からの最高血圧低下度を求めるものとされ、判定手段にて最高血圧及び最高血圧低下度が所定閾値を超えたか否か判定するとともに、報知手段にて最高血圧又は最高血圧低下度が所定閾値を超えたと判定されたことを条件として、当該最高血圧又は最高血圧低下度に応じた所定の報知を行わせるので、最高血圧及び最高血圧低下度を有効活用して患者の異常を精度よく報知することができる。   According to the invention of claim 3, the calculating means obtains the maximum blood pressure and the maximum blood pressure lowering level from the start of blood purification treatment based on the detected value by the blood pressure detecting means in addition to the pulse pressure, the average blood pressure and the minimum blood pressure. The determination means determines whether or not the maximum blood pressure and the maximum blood pressure decrease level exceed a predetermined threshold, and the notification means determines that the maximum blood pressure or the maximum blood pressure decrease level exceeds the predetermined threshold. Since the predetermined notification according to the maximum blood pressure or the maximum blood pressure lowering level is performed, the abnormalities of the patient can be accurately notified by effectively utilizing the maximum blood pressure and the maximum blood pressure decreasing level.

請求項4の発明によれば、算出手段は、脈圧、平均血圧及び最低血圧に加え、血圧検出手段による検出値に基づいて、脈拍数及び該脈拍数に最高血圧を乗算して求められるPRPを求めるものとされ、判定手段にて脈拍数及びPRPが所定閾値を超えたか否か判定するとともに、報知手段にて脈拍数又はPRPが所定閾値を超えたと判定されたことを条件として、当該脈拍数又はPRPに応じた所定の報知を行わせるので、脈拍数及びPRPを有効活用して患者の異常を精度よく報知することができる。   According to the invention of claim 4, the calculating means is a PRP obtained by multiplying the pulse rate and the pulse rate by the maximum blood pressure based on the detected value by the blood pressure detecting means in addition to the pulse pressure, the average blood pressure and the minimum blood pressure. If the determination means determines whether the pulse rate and PRP have exceeded a predetermined threshold, and the notification means determines that the pulse rate or PRP has exceeded the predetermined threshold, the pulse Since the predetermined notification according to the number or PRP is performed, the patient's abnormality can be accurately notified by effectively utilizing the pulse rate and PRP.

請求項5の発明によれば、報知手段は、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段から成り、当該表示手段によって、算出手段で求められた算出値と血液浄化治療中の循環血液量の変化率とが併せて表示されるので、循環血液量の変化率と算出手段で求められた算出値とを関連させて監視することができる。   According to the invention of claim 5, the notifying means comprises display means capable of displaying information related to blood purification treatment in real time, and the calculated value obtained by the calculating means and the circulation during blood purification treatment by the display means. Since the change rate of the blood volume is displayed together, it is possible to monitor the change rate of the circulating blood volume and the calculated value obtained by the calculation means in association with each other.

請求項6の発明によれば、血液浄化治療中の患者の心電図を測定し得る心電図用測定手段と、該心電図用測定手段からの測定信号に基づいて心電図を得る心電図取得手段とを具備するとともに、判定手段にて心電図取得手段で取得された心電図に異常があるか否かを判定するとともに、心電図に異常があると判定されたことを条件として、報知手段にて当該心電図の異常に応じた所定の報知を行わせるので、血圧に関するパラメータに加え、心電図取得手段で取得された心電図を活用して患者の異常をより精度よく報知することができる。   According to the invention of claim 6, there is provided an electrocardiogram measuring means capable of measuring an electrocardiogram of a patient undergoing blood purification treatment, and an electrocardiogram acquiring means obtaining an electrocardiogram based on a measurement signal from the electrocardiogram measuring means. The determination means determines whether or not the electrocardiogram acquired by the electrocardiogram acquisition means is abnormal, and the notification means responds to the abnormality of the electrocardiogram on the condition that the electrocardiogram is determined to be abnormal Since the predetermined notification is performed, it is possible to notify the patient's abnormality more accurately by utilizing the electrocardiogram acquired by the electrocardiogram acquisition means in addition to the blood pressure parameter.

請求項7の発明によれば、心電図取得手段で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得る解析手段を具備するとともに、当該解析手段による心拍変動解析の結果に応じて判定手段による判定が行われるので、自律神経機能を勘案した判定を行わせることができる。   According to the seventh aspect of the present invention, the analysis means capable of performing the heart rate variability analysis based on the electrocardiogram acquired by the electrocardiogram acquisition means and evaluating the autonomic nerve function, and according to the result of the heart rate variability analysis by the analysis means. Since the determination by the determination means is performed, it is possible to make a determination in consideration of the autonomic nerve function.

請求項8の発明によれば、心電図取得手段及び解析手段は、血液浄化治療中の患者の近傍に配設されたベッドサイド端末装置、又は血液浄化治療に関わる条件又は情報を送信し得る中央監視装置に配設されたので、従来の血液浄化装置が具備するベッドサイド端末装置又は中央監視装置を流用することができる。   According to the invention of claim 8, the electrocardiogram acquisition means and the analysis means are a bedside terminal device disposed in the vicinity of a patient undergoing blood purification treatment, or central monitoring capable of transmitting conditions or information relating to blood purification treatment. Since it is disposed in the device, the bedside terminal device or the central monitoring device provided in the conventional blood purification device can be used.

請求項9の発明によれば、報知手段は、算出手段で算出された算出値に基づいて推定される患者の状態を表示し得るので、算出手段で算出された算出値を単に表示させるものに比べ、医師等医療従事者に対して患者の状態をより容易に把握させることができる。   According to the ninth aspect of the present invention, the notifying means can display the patient state estimated based on the calculated value calculated by the calculating means, so that the calculated value calculated by the calculating means is simply displayed. In comparison, a medical staff such as a doctor can more easily grasp the patient's condition.

本発明の第1の実施形態に係る血液浄化装置を示す模式図The schematic diagram which shows the blood purification apparatus which concerns on the 1st Embodiment of this invention. 同血液浄化装置における治療手段を示す模式図Schematic diagram showing treatment means in the blood purification apparatus 同血液浄化装置における治療手段(透析装置本体)の内部構成を示す模式図The schematic diagram which shows the internal structure of the treatment means (dialyzer main body) in the blood purification apparatus 同血液浄化装置における透析装置本体の外観を示す斜視図The perspective view which shows the external appearance of the dialyzer main body in the blood purification apparatus 同血液浄化装置における制御内容を示すフローチャートFlow chart showing control contents in the blood purification apparatus 本発明の第2の実施形態に係る血液浄化装置を示す模式図The schematic diagram which shows the blood purification apparatus which concerns on the 2nd Embodiment of this invention. 同血液浄化装置における制御内容を示すフローチャートFlow chart showing control contents in the blood purification apparatus

以下、本発明の実施形態について図面を参照しながら具体的に説明する。
第1の実施形態に係る血液浄化装置は、図1に示すように、治療手段1と、血圧検出手段2と、入力手段3と、算出手段4と、判定手段5と、制御手段6と、表示手段7(本発明の「報知手段」に相当)とを主に有して構成されている。なお、本実施形態においては、透析装置本体Hに入力手段3、算出手段4、判定手段5、制御手段6及び表示手段7が配設されている。
Hereinafter, embodiments of the present invention will be specifically described with reference to the drawings.
As shown in FIG. 1, the blood purification apparatus according to the first embodiment includes a treatment means 1, a blood pressure detection means 2, an input means 3, a calculation means 4, a determination means 5, a control means 6, It mainly comprises display means 7 (corresponding to “notification means” of the present invention). In the present embodiment, the dialyzer main body H is provided with an input unit 3, a calculation unit 4, a determination unit 5, a control unit 6, and a display unit 7.

本実施形態に係る治療手段1は、患者の血液を体外循環させつつ血液透析処理及び除水を行って血液浄化治療を行うためのものであり、図2、3に示すように、患者の血液を体外循環させるための血液回路8と、該血液回路8に接続されて血液透析処理を行うための血液浄化器としてのダイアライザ9と、該ダイアライザ9に接続されて透析液を供給しつつ除水する透析装置本体Hとから主に構成されている。   The treatment means 1 according to this embodiment is for performing blood purification treatment by performing hemodialysis and water removal while circulating the patient's blood extracorporeally. As shown in FIGS. A blood circuit 8 for circulating the blood outside the body, a dialyzer 9 connected to the blood circuit 8 for blood dialysis, and a water purifier connected to the dialyzer 9 and supplying dialysate The dialysis machine main body H is mainly composed.

血液回路8は、血液等の液体を流通させ得る可撓性チューブから成り、動脈側血液回路8a及び静脈側血液回路8bを有して構成されている。動脈側血液回路8aには、その先端に動脈側穿刺針aが接続可能とされているとともに、途中にしごき型の血液ポンプ10、及びヘマトクリットセンサ12が配設されている。一方、静脈側血液回路8bには、その先端に静脈側穿刺針bが接続されているとともに、途中に除泡用のエアトラップチャンバ11が接続されている。   The blood circuit 8 is made of a flexible tube through which a fluid such as blood can flow, and has an arterial blood circuit 8a and a venous blood circuit 8b. An arterial puncture needle a can be connected to the tip of the arterial blood circuit 8a, and an iron-type blood pump 10 and a hematocrit sensor 12 are disposed in the middle. On the other hand, a venous puncture needle b is connected to the distal end of the venous blood circuit 8b, and an air trap chamber 11 for defoaming is connected midway.

ヘマトクリットセンサ12は、例えばLED等の発光素子及びフォトダイオード等の受光素子を備え、発光素子から血液に所定波長の光を照射するとともに、その透過した光或いは反射した光を受光素子にて受光することにより、血液回路8内を流れる患者の血液の濃度を示すヘマトクリット値を測定するものである。なお、ヘマトクリット値とは、血液の濃度を示す指標であり、具体的には、全血に占める赤血球の容積率で表されるものである。   The hematocrit sensor 12 includes a light-emitting element such as an LED and a light-receiving element such as a photodiode. The hematocrit sensor 12 irradiates blood with a predetermined wavelength from the light-emitting element, and receives the transmitted or reflected light by the light-receiving element. Thus, the hematocrit value indicating the concentration of the blood of the patient flowing in the blood circuit 8 is measured. The hematocrit value is an index indicating the blood concentration, and is specifically expressed by the volume ratio of red blood cells in whole blood.

本実施形態においては、ヘマトクリットセンサ12で検出されたヘマトクリット値に基づいて循環血液量の変化率(ΔBV)を求めることができるよう構成されている。具体的には、ヘマトクリットセンサ12にて得られるヘマトクリット値をHtとおくと、循環血液量の変化率ΔBVは、(透析開始時のHt−測定時のHt)/測定時のHt×100なる演算式から求めることができる。これにより、透析治療時間経過に伴って患者の循環血液量の変化率(ΔBV)を逐次検出することができる。   In the present embodiment, the change rate (ΔBV) of the circulating blood volume can be obtained based on the hematocrit value detected by the hematocrit sensor 12. Specifically, if the hematocrit value obtained by the hematocrit sensor 12 is Ht, the change rate ΔBV of the circulating blood volume is (Ht at the start of dialysis−Ht at the time of measurement) / Ht × 100 at the time of measurement. It can be obtained from the formula. Thereby, the change rate (ΔBV) of the circulating blood volume of the patient can be sequentially detected as the dialysis treatment time elapses.

しかして、動脈側穿刺針a及び静脈側穿刺針bを患者に穿刺した状態で、血液ポンプ10を駆動させると、患者の血液は、動脈側血液回路8aを通ってダイアライザ9に至り、該ダイアライザ9によって血液浄化が施され、エアトラップチャンバ11で除泡がなされつつ静脈側血液回路8bを通って患者の体内に戻る。これにより、患者の血液を血液回路8にて体外循環させつつダイアライザ9にて浄化することができるのである。   Thus, when the blood pump 10 is driven with the patient punctured with the arterial puncture needle a and the vein puncture needle b, the blood of the patient reaches the dialyzer 9 through the arterial blood circuit 8a. The blood is purified by the air trap 9 and defoamed in the air trap chamber 11 and returns to the patient's body through the venous blood circuit 8b. Thus, the blood of the patient can be purified by the dialyzer 9 while circulating outside the body by the blood circuit 8.

ダイアライザ9は、その筐体部に、血液導入ポート9a、血液導出ポート9b、透析液導入ポート9c及び透析液導出ポート9dが形成されており、このうち血液導入ポート9aには動脈側血液回路8aの基端が、血液導出ポート9bには静脈側血液回路8bの基端がそれぞれ接続されている。また、透析液導入ポート9c及び透析液導出ポート9dは、透析装置本体Hから延設された透析液導入ラインL1及び透析液排出ラインL2とそれぞれ接続されている。   The dialyzer 9 is formed with a blood introduction port 9a, a blood outlet port 9b, a dialysate inlet port 9c, and a dialysate outlet port 9d in the casing. Among these, the blood inlet port 9a has an arterial blood circuit 8a. The base end of the venous blood circuit 8b is connected to the blood outlet port 9b. The dialysate introduction port 9c and the dialysate lead-out port 9d are connected to a dialysate introduction line L1 and a dialysate discharge line L2 extending from the dialyzer body H, respectively.

ダイアライザ9の筐体部内には、複数の中空糸が収容されており、該中空糸内部が血液の流路とされるとともに、中空糸外周面と筐体部の内周面との間が透析液の流路とされている。中空糸には、その外周面と内周面とを貫通した微少な孔(ポア)が多数形成されて中空糸膜を形成しており、該膜を介して血液中の不純物等が透析液内に透過し得るよう構成されている。   A plurality of hollow fibers are accommodated in the casing portion of the dialyzer 9, and the inside of the hollow fibers is used as a blood flow path, and the space between the outer peripheral surface of the hollow fibers and the inner peripheral surface of the casing portion is dialyzed. It is a liquid flow path. A hollow fiber membrane is formed in the hollow fiber by forming a large number of minute holes (pores) penetrating the outer circumferential surface and the inner circumferential surface, and impurities in the blood are passed through the membrane in the dialysate. It is comprised so that it can permeate | transmit.

透析装置本体Hは、図3に示すように、透析液導入ラインL1及び透析液排出ラインL2に跨って形成された複式ポンプPと、透析液排出ラインL2において複式ポンプPを迂回して接続されたバイパスラインL3と、該バイパスラインL3に接続された除水ポンプ13とを有して構成されている。そして、透析液導入ラインL1の一端がダイアライザ9(透析液導入ポート9c)に接続されるとともに、他端が所定濃度の透析液を調製する透析液供給装置(不図示)に接続されている。また、透析液排出ラインL2の一端は、ダイアライザ9(透析液導出ポート9d)に接続されるとともに、他端が排液手段(不図示)と接続されており、透析液供給装置から供給された透析液が透析液導入ラインL1を通ってダイアライザ9に至った後、透析液排出ラインL2及びバイパスラインL3を通って排液手段に送られるようになっている。   As shown in FIG. 3, the dialysis machine main body H is connected to the dual pump P formed across the dialysate introduction line L1 and the dialysate discharge line L2, bypassing the dual pump P in the dialysate discharge line L2. And the dewatering pump 13 connected to the bypass line L3. One end of the dialysate introduction line L1 is connected to the dialyzer 9 (dialyte introduction port 9c), and the other end is connected to a dialysate supply device (not shown) for preparing a dialysate having a predetermined concentration. In addition, one end of the dialysate discharge line L2 is connected to the dialyzer 9 (dialysate outlet port 9d), and the other end is connected to a drainage means (not shown) and supplied from the dialysate supply device. After the dialysate reaches the dialyzer 9 through the dialysate introduction line L1, the dialysate is sent to the drainage means through the dialysate discharge line L2 and the bypass line L3.

除水ポンプ13は、ダイアライザ9中を流れる患者の血液から水分を除去するためのものである。すなわち、除水ポンプ13を駆動させると、透析液導入ラインL1から導入される透析液量よりも透析液排出ラインL2から排出される液体の容量が多くなり、その多い容量分だけ血液中から水分が除去されるのである。なお、除水ポンプ13以外の手段(例えば所謂バランシングチャンバ等を利用するもの)にて患者の血液から水分を除去するようにしてもよい。   The dewatering pump 13 is for removing water from the blood of the patient flowing through the dialyzer 9. That is, when the dewatering pump 13 is driven, the volume of the liquid discharged from the dialysate discharge line L2 becomes larger than the amount of dialysate introduced from the dialysate introduction line L1, and moisture from the blood is increased by the larger volume. Is removed. In addition, you may make it remove a water | moisture content from a patient's blood by means other than the water removal pump 13 (for example, what utilizes what is called a balancing chamber etc.).

なお、透析装置本体H内における透析液排出ラインL2に排液濃度センサを配設してもよい。この排液濃度センサは、血液浄化に伴って流れる液体(本実施形態においては、血液浄化器としてのダイアライザ9から排出された排液)の濃度(例えば、排液に含まれる尿素、尿酸等の物質濃度)を検出し得るものである。かかる排液濃度センサによれば、検出した排液の濃度変化に基づいて標準化透析量(Kt/V)を求めることができ、透析治療時間経過に伴って標準化透析量(Kt/V)を逐次検出することができる。   A drainage concentration sensor may be provided in the dialysate discharge line L2 in the dialyzer body H. This drainage concentration sensor is a concentration of a liquid that flows along with blood purification (in this embodiment, drainage discharged from a dialyzer 9 as a blood purifier) (for example, urea, uric acid, etc. contained in the drainage). (Substance concentration) can be detected. According to such a drainage concentration sensor, the standardized dialysis amount (Kt / V) can be obtained based on the detected concentration change of the drainage, and the standardized dialysis amount (Kt / V) is sequentially obtained as the dialysis treatment time elapses. Can be detected.

透析装置本体Hは、図4に示すように、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段7を具備している。この表示手段7は、例えばタッチパネル式の液晶画面に種々情報を表示し得るもので、制御手段6(図1参照)にて表示内容が制御される。例えば、表示手段7の液晶画面には、治療中に逐次算出されたΔBVのグラフを時系列に表示させるとともに、現在のΔBV、ΔBVの変化率等が数値として表示させることができる。   As shown in FIG. 4, the dialysis machine main body H includes display means 7 that can display information related to blood purification treatment in real time. The display means 7 can display various information on, for example, a touch panel type liquid crystal screen, and the display content is controlled by the control means 6 (see FIG. 1). For example, on the liquid crystal screen of the display means 7, a graph of ΔBV sequentially calculated during treatment can be displayed in time series, and the current ΔBV, ΔBV change rate, etc. can be displayed as numerical values.

ここで、本実施形態に係る血液浄化装置には、血液浄化治療中の患者の血圧及び脈拍を検出し得る血圧検出手段2が接続されている。かかる血圧検出手段2は、患者の腕にカフを巻き付けて、その患者の血圧(最高血圧及び最低血圧等の血圧に関するパラメータ)及び脈拍を測定し得る血圧計から成り、透析装置本体Hに配設された入力手段3と電気的に接続されている。因みに、心拍とは心臓の拍動を、脈拍とは心臓が血液を全身に送る際に生じる動脈の脈動を指すもので、両者は原則として同一値になることが多いが、不整脈等により、両者が一致しないこともある。   Here, the blood purification apparatus according to the present embodiment is connected to blood pressure detection means 2 that can detect the blood pressure and pulse of the patient undergoing blood purification treatment. The blood pressure detection means 2 is composed of a sphygmomanometer that can measure a blood pressure (parameters related to blood pressure such as maximum blood pressure and minimum blood pressure) and a pulse of the patient by wrapping a cuff around the arm of the patient, and is disposed in the dialyzer main body H. The input means 3 is electrically connected. By the way, the heartbeat refers to the pulsation of the heart, and the pulsation refers to the pulsation of the arteries that occurs when the heart sends blood to the whole body. May not match.

なお、本実施形態に係る血圧検出手段2は、患者の腕に巻かれて血圧及び脈拍を検出し得るカフ等から成り、その検出結果を入力手段3を介して算出手段4に送信し、算出手段4により、血液浄化治療中、間歇的に血圧及び脈拍を得るものとされているが、これに代えて、血圧検出手段2内に算出手段4を内蔵させたものとしてもよい。さらに、血圧検出手段2は、連続的且つリアルタイムで血圧及び脈拍を測定し得るものとしてもよく、例えば外部接続する生体情報モニタリング機器等を用いて血圧及び脈拍を連続的且つリアルタイムで測定することにより、より精度よく患者の異常を判定することができる。   The blood pressure detection means 2 according to the present embodiment is composed of a cuff or the like that can be wound around the patient's arm and can detect the blood pressure and the pulse, and the detection result is transmitted to the calculation means 4 via the input means 3 for calculation. The means 4 obtains blood pressure and pulse intermittently during the blood purification treatment, but instead of this, the blood pressure detection means 2 may incorporate the calculation means 4. Further, the blood pressure detection means 2 may be capable of measuring blood pressure and pulse continuously and in real time, for example, by measuring blood pressure and pulse continuously and in real time using an externally connected biological information monitoring device or the like. Therefore, it is possible to determine the abnormality of the patient with higher accuracy.

入力手段3は、血圧検出手段2からの検出値を受信するもので、算出手段4と電気的に接続されており、血圧検出手段2からの検出値を入力手段3を介して算出手段4に送信し得るようになっている。算出手段4は、血圧検出手段2による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求めるもので、本実施形態においては、当該脈圧、平均血圧及び最低血圧の他、最高血圧、最高血圧低下度、脈拍数及びPRPをそれぞれ算出するよう構成されている。   The input unit 3 receives a detection value from the blood pressure detection unit 2 and is electrically connected to the calculation unit 4. The detection unit 2 receives the detection value from the blood pressure detection unit 2 via the input unit 3. It can be sent. The calculation means 4 obtains at least the pulse pressure, the average blood pressure, and the minimum blood pressure based on the detection value by the blood pressure detection means 2, and in this embodiment, in addition to the pulse pressure, the average blood pressure, and the minimum blood pressure, the maximum blood pressure is calculated. The maximum blood pressure lowering degree, the pulse rate, and the PRP are calculated.

最高血圧は、心臓の収縮期血圧、及び最低血圧は、心臓の拡張期血圧から成り、それぞれ血圧検出手段2にて測定された血圧の最高値及び最低値を示すものである。このうち、最低血圧は、交感神経が抗進することで血管が収縮するため比較的維持されるとともに、心臓の拡張期で冠動脈に血液が流れるため、冠動脈血流量の指標となり得る。最高血圧低下度は、血液浄化治療開始から測定時点までに最高血圧が低下した程度を示すもので、「血液浄化治療開始時の最高血圧−現在の最高血圧」なる演算式で求めることができる。   The systolic blood pressure of the heart and the diastolic blood pressure of the heart are diastolic blood pressure of the heart, and indicate the maximum and minimum values of the blood pressure measured by the blood pressure detecting means 2, respectively. Among these, the minimum blood pressure is relatively maintained because the blood vessels contract as the sympathetic nerves advance, and the blood flows into the coronary arteries during the diastole of the heart. The systolic blood pressure lowering degree indicates the degree to which the systolic blood pressure has decreased from the start of blood purification treatment to the time of measurement, and can be obtained by an arithmetic expression “maximum blood pressure at the start of blood purification treatment—current systolic blood pressure”.

平均血圧は、最低血圧+(脈圧/3)(脈圧は、下記の通り、「最高血圧−最低血圧」なる演算式で求められる)なる演算式で求めることができ、末梢の動脈硬化の指標として用いることができる。この平均血圧は、血管内に血液を流す力を示すことから、重要臓器の血流状態の指標となり得る。脈圧は、最高血圧−最低血圧なる演算式(最高血圧と最低血圧との差)で求めることができ、中枢の動脈硬化の指標として用いることができる。この脈圧は、最高血圧よりも敏感に循環血液量や心拍数を反映することから、循環管理に適した指標となり得る。   The average blood pressure can be obtained by an arithmetic expression of minimum blood pressure + (pulse pressure / 3) (the pulse pressure is obtained by an arithmetic expression “maximum blood pressure−minimum blood pressure” as described below). It can be used as an indicator. This average blood pressure indicates the force of flowing blood into the blood vessel, and can be an indicator of the blood flow state of important organs. The pulse pressure can be obtained by an arithmetic expression (maximum blood pressure−minimum blood pressure) of maximum blood pressure−minimum blood pressure, and can be used as an index of central arteriosclerosis. This pulse pressure reflects the circulated blood volume and heart rate more sensitively than the maximum blood pressure, and can be an index suitable for circulatory management.

PRPは、最高血圧×脈拍数なる演算式(最高血圧と心拍数の積)で求めることができ、非侵襲的に心筋酸素消費量の指標を得ることができる。運動負荷心電図検査等で使用されており、心臓の労作強度を計測するパラメータとして知られている。透析治療(血液浄化治療)においても、循環動態が大きく変化しており、心臓に対する負担が増大しているため、有用なパラメータの一つである。   The PRP can be obtained by an arithmetic expression (maximum blood pressure × pulse rate) (product of the maximum blood pressure and the heart rate), and an index of myocardial oxygen consumption can be obtained non-invasively. It is used in exercise electrocardiogram examinations, etc., and is known as a parameter for measuring the intensity of work of the heart. In dialysis treatment (blood purification treatment), the circulatory dynamics are greatly changed and the burden on the heart is increased, which is one of useful parameters.

上記のように、最高血圧及び最低血圧のみならず、平均血圧、脈圧及びPRP等を算出して血液浄化治療時の監視に用いることは、血圧低下の予測に有効であり、このとき、脈拍及び脈拍数も同時に検出及び算出することができるので、より監視の精度を向上させることができる。なお、脈拍数で収縮期血圧を除算(最高血圧/脈拍数)することで得られるショック指数を利用してもよい。このショック指数は、循環血液量減少性ショックの重症度を把握するために用いることができる。   As described above, calculating not only the maximum blood pressure and the minimum blood pressure but also the average blood pressure, the pulse pressure, and the PRP and using them for monitoring during blood purification treatment is effective for predicting a decrease in blood pressure. In addition, since the pulse rate can be detected and calculated at the same time, the monitoring accuracy can be further improved. A shock index obtained by dividing the systolic blood pressure by the pulse rate (maximum blood pressure / pulse rate) may be used. This shock index can be used to determine the severity of circulating blood volume reducing shock.

判定手段5は、算出手段4と電気的に接続され、当該算出手段4で求められた脈圧、平均血圧及び最低血圧(本実施形態においては、脈圧、平均血圧及び最低血圧に加えて、脈拍数、PRP、最高血圧及び最高血圧低下度)がそれぞれ所定閾値を超えたか否か判定するものである。所定閾値は、判定対象である血圧のパラメータに応じて予め定められたもので、異常値と正常値との境界値とされている。   The determination means 5 is electrically connected to the calculation means 4, and the pulse pressure, average blood pressure and minimum blood pressure obtained by the calculation means 4 (in this embodiment, in addition to the pulse pressure, average blood pressure and minimum blood pressure, It is determined whether or not the pulse rate, PRP, systolic blood pressure, and systolic blood pressure lowering level) exceed predetermined threshold values. The predetermined threshold is predetermined according to the blood pressure parameter to be determined, and is a boundary value between the abnormal value and the normal value.

制御手段6は、表示手段7の表示内容を制御するためのもので、治療手段1、判定手段5及び表示手段7と電気的に接続されるとともに、治療手段1の作動状態や設定状態、判定手段5による判定結果等を表示手段7の画面に表示させ得るよう構成されている。表示手段7は、本発明の報知手段を構成するもので、判定手段5にて脈圧、最低血圧又は平均血圧等(本実施形態においては、脈圧、平均血圧及び最低血圧に加えて、脈拍数、PRP、最高血圧及び最高血圧低下度)が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧等に応じた所定の報知(表示による報知)を行わせるものである。   The control means 6 is for controlling the display content of the display means 7 and is electrically connected to the treatment means 1, the determination means 5 and the display means 7, and the operating state, setting state, and determination of the treatment means 1. The result of determination by the means 5 can be displayed on the screen of the display means 7. The display means 7 constitutes the notification means of the present invention. The determination means 5 uses the pulse pressure, the minimum blood pressure, the average blood pressure or the like (in this embodiment, in addition to the pulse pressure, the average blood pressure, and the minimum blood pressure, Number, PRP, systolic blood pressure, and systolic blood pressure lowering level) are determined to have exceeded a predetermined threshold value, and a predetermined notification (notification by display) is performed according to the pulse pressure, the minimum blood pressure, or the average blood pressure. Is.

さらに、本実施形態においては、脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで表示手段7(報知手段)による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせるようになっている。   Furthermore, in the present embodiment, the first state in which the pulse pressure exceeds the predetermined threshold value, and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold value, and the pulse pressure exceeds the predetermined threshold value, and the minimum blood pressure and the average blood pressure The notification mode regarding the degree of danger by the display means 7 (notification means) is different from that in the second state in which at least one of the blood pressures exceeds a predetermined threshold, and the degree of danger in the second state is higher than that in the first state. A notification to that effect is made.

またさらに、本実施形態に係る報知手段は、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段7から成り、当該表示手段7によって、算出手段4で求められた算出値と血液浄化治療中の循環血液量の変化率(ΔBV)とが併せて表示されるようになっている。すなわち、表示手段7には、血液浄化治療中の循環血液量の変化率(ΔBV)と併せて、患者の脈圧、平均血圧及び最低血圧の他、最高血圧、最高血圧低下度、脈拍数及びPRP等の血圧に関する種々パラメータが表示可能とされているのである。   Furthermore, the notifying unit according to the present embodiment includes a display unit 7 that can display information related to blood purification treatment in real time, and the display unit 7 calculates the calculated value obtained by the calculation unit 4 and the blood purification treatment in progress. The rate of change in the circulating blood volume (ΔBV) is also displayed. That is, the display means 7 includes the blood pressure change rate (ΔBV) during blood purification treatment, the patient's pulse pressure, mean blood pressure, and lowest blood pressure, as well as the highest blood pressure, the highest blood pressure drop, the pulse rate and Various parameters relating to blood pressure such as PRP can be displayed.

次に、本実施形態に係る血液浄化装置における判定手段5の判定方法について、図5のフローチャートに基づいて説明する。
まず、血圧検出手段2の検出値に基づいて算出手段4で算出された脈拍数が所定閾値(例えば100(bpm))を超えたか否かが判定され(S1)、所定閾値を超えたと判定されると、患者が頻脈状態である旨を表示手段7にて表示して報知する(S2)。その後、算出手段4で算出されたPRPが所定閾値(例えば12000)を超えたか否かが判定され(S3)、所定閾値を超えたと判定されると、患者が心筋虚血状態の可能性がある旨を表示手段7にて表示して報知する(S4)。なお、PRPが所定閾値を超えない場合、S4をスキップしてS5に進む。
Next, the determination method of the determination means 5 in the blood purification apparatus according to the present embodiment will be described based on the flowchart of FIG.
First, it is determined whether or not the pulse rate calculated by the calculation means 4 based on the detection value of the blood pressure detection means 2 exceeds a predetermined threshold (for example, 100 (bpm)) (S1), and it is determined that the predetermined threshold is exceeded. Then, the display means 7 displays and notifies that the patient is in a tachycardia state (S2). Thereafter, it is determined whether or not the PRP calculated by the calculation means 4 exceeds a predetermined threshold (for example, 12000) (S3), and if it is determined that the predetermined threshold is exceeded, the patient may have a myocardial ischemia state. A message to that effect is displayed on the display means 7 (S4). If PRP does not exceed the predetermined threshold, S4 is skipped and the process proceeds to S5.

一方、S1にて脈拍数が所定閾値を超えていないと判定されると、S17に進み、脈拍数が所定閾値(S1で判定される所定閾値より低い値であって、例えば50(bpm))を超えたか否かが判定され(S17)、所定閾値を超えない場合、S18にて患者が徐脈状態である旨を表示手段7にて表示して報知した後、一連の制御を終了させる。なお、S17にて脈拍数が所定閾値を超えたと判定されると、S5に進むこととなる。   On the other hand, if it is determined in S1 that the pulse rate does not exceed the predetermined threshold value, the process proceeds to S17, and the pulse rate is a predetermined threshold value (a value lower than the predetermined threshold value determined in S1, for example, 50 (bpm)). (S17). If the predetermined threshold is not exceeded, the display means 7 displays and notifies that the patient is in a bradycardia state in S18, and then the series of controls is terminated. If it is determined in S17 that the pulse rate has exceeded the predetermined threshold value, the process proceeds to S5.

S5においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最高血圧が所定閾値(例えば90(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者の最高血圧が低下した状態である旨を表示手段7にて表示して報知する(S6)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S6をスキップしてS7に進む。   In S5, it is determined whether or not the maximum blood pressure calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 90 (mmHg)) based on the detection value of the blood pressure detection unit 2, and exceeds the predetermined threshold (in this case) If it is determined that the patient's systolic blood pressure has fallen, the display means 7 displays and notifies the display means 7 (S6), and the predetermined value is not exceeded (in this case, the predetermined value is not exceeded). If it is determined that the threshold value has been exceeded, the process skips S6 and proceeds to S7.

S7においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最高血圧低下度が所定閾値(例えば30(mmHg))を超えたか否かが判定され、所定閾値を超えたと判定されると、患者の最高血圧低下度を表示手段7にて表示して報知する(S8)とともに、所定値を超えないと判定されると、S8をスキップしてS9に進む。   In S7, it is determined whether or not the maximum blood pressure reduction degree calculated by the calculation means 4 based on the detection value of the blood pressure detection means 2 exceeds a predetermined threshold (for example, 30 (mmHg)), and it is determined that the predetermined threshold is exceeded. Then, the patient's systolic blood pressure lowering degree is displayed and notified on the display means 7 (S8), and if it is determined that the predetermined value is not exceeded, S8 is skipped and the process proceeds to S9.

S9においては、血圧検出手段2の検出値に基づいて算出手段4で算出された脈圧(循環動態の指標)が所定閾値(例えば30(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が脈圧低下状態である旨を表示手段7にて表示して報知する(S10)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S10をスキップしてS11、S13に進む。ここで、本実施形態においては、S10にて、患者の治療中における危険度が中程度として報知するよう構成されている。   In S9, it is determined whether or not the pulse pressure (circulation dynamic index) calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 30 (mmHg)) based on the detection value of the blood pressure detection unit 2. (In this case, it is below a predetermined threshold value), the display means 7 displays and notifies that the patient is in a reduced pulse pressure state (S10), and does not exceed the predetermined value ( In this case, if it is determined that the value exceeds a predetermined threshold value, S10 is skipped and the process proceeds to S11 and S13. Here, in the present embodiment, in S10, it is configured to notify that the degree of risk during the treatment of the patient is medium.

S11においては、血圧検出手段2の検出値に基づいて算出手段4で算出された平均血圧(重要臓器の血流量の指標)が所定閾値(例えば60(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が平均血圧低下状態である旨を表示手段7にて表示して報知する(S12)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S12をスキップしてS15に進む。   In S11, it is determined whether or not the average blood pressure (index of blood flow of an important organ) calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 60 (mmHg)) based on the detection value of the blood pressure detection unit 2. If it is determined that the predetermined threshold value is exceeded (in this case, the predetermined threshold value is exceeded), the display means 7 displays and notifies that the patient is in an average blood pressure lowering state (S12), and the predetermined value is set. If it is determined that it does not exceed (in this case, a predetermined threshold value is exceeded), S12 is skipped and the process proceeds to S15.

S13においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最低血圧(冠動脈血流量の指標)が所定閾値(例えば40(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が最低血圧低下状態である旨を表示手段7にて表示して報知する(S14)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S14をスキップしてS15に進む。   In S13, it is determined whether or not the minimum blood pressure (coronary blood flow index) calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 40 (mmHg)) based on the detection value of the blood pressure detection unit 2, If it is determined that the threshold value has been exceeded (in this case, the value has fallen below the predetermined threshold value), the display means 7 displays and notifies that the patient is in the lowest blood pressure lowering state (S14) and does not exceed the predetermined value. If it is determined (in this case, the value exceeds the predetermined threshold), S14 is skipped and the process proceeds to S15.

S15においては、S10による報知が行われ、且つ、S12による報知又はS14による報知が行われたか否かが判定され、S10による報知が行われ、且つ、S12による報知又はS14による報知が行われたと判定されると、S16にて患者の治療中における危険度が高い状態として報知するとともに、S10による報知が行われ、且つ、S12による報知及びS14による報知が行われない場合、S16をスキップして一連の制御が終了するよう構成されている。すなわち、脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで表示手段7(報知手段)による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせるようになっているのである。   In S15, it is determined whether notification by S10 has been performed, whether notification by S12 or notification by S14 has been performed, notification by S10 has been performed, and notification by S12 or notification by S14 has been performed. If determined, in S16, the patient is informed that the degree of risk during treatment is high, the notification in S10 is performed, and if the notification in S12 and the notification in S14 are not performed, S16 is skipped. A series of controls are configured to end. That is, the first state in which the pulse pressure exceeds a predetermined threshold and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold, and at least one of the minimum blood pressure and the average blood pressure is predetermined. The notification form regarding the degree of risk by the display means 7 (notification means) is different from that in the second state exceeding the threshold value, and the second state is notified that the degree of risk is higher than the first state. It is like that.

上記実施形態によれば、血圧検出手段2による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求める算出手段4と、算出手段4で求められた脈圧、平均血圧及び最低血圧がそれぞれ所定閾値を超えたか否か判定する判定手段5と、判定手段5にて脈圧、最低血圧又は平均血圧が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧に応じた所定の報知を行わせる表示手段7(報知手段)とを備えたので、血圧に関するパラメータを有効活用して患者の異常を精度よく報知することができる。   According to the above embodiment, the calculation means 4 for obtaining at least the pulse pressure, the average blood pressure and the minimum blood pressure based on the detection value by the blood pressure detection means 2, and the pulse pressure, the average blood pressure and the minimum blood pressure obtained by the calculation means 4 are Each of the determination means 5 for determining whether or not the predetermined threshold value is exceeded, and on the condition that the determination means 5 determines that the pulse pressure, minimum blood pressure or average blood pressure exceeds the predetermined threshold value, the pulse pressure, minimum blood pressure or average Since the display means 7 (notification means) for performing a predetermined notification according to the blood pressure is provided, it is possible to effectively notify the abnormality of the patient by effectively using the parameters relating to the blood pressure.

また、脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで報知手段による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせるので、危険度の重み付け(危険度の軽重付け)を行って報知することができる。   In addition, a first state in which the pulse pressure exceeds a predetermined threshold value and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold value, and the pulse pressure exceeds the predetermined threshold value, and at least one of the minimum blood pressure and the average blood pressure is predetermined Since the notification mode regarding the degree of risk by the notification means is different between the second state exceeding the threshold and the second state is informed that the degree of risk is higher than the first state, It is possible to notify by performing weighting (weighting of the risk level).

さらに、本実施形態に係る算出手段4は、脈圧、平均血圧及び最低血圧に加え、血圧検出手段2による検出値に基づいて、最高血圧及び血液浄化治療開始からの最高血圧低下度を求めるものとされ、判定手段5にて最高血圧及び最高血圧低下度が所定閾値を超えたか否か判定するとともに、表示手段7(報知手段)にて最高血圧又は最高血圧低下度が所定閾値を超えたと判定されたことを条件として、当該最高血圧又は最高血圧低下度に応じた所定の報知を行わせるので、最高血圧及び最高血圧低下度を有効活用して患者の異常を精度よく報知することができる。   Further, the calculation means 4 according to the present embodiment obtains the maximum blood pressure and the maximum blood pressure decrease level from the start of blood purification treatment based on the detection value by the blood pressure detection means 2 in addition to the pulse pressure, the average blood pressure and the minimum blood pressure. The determination means 5 determines whether or not the maximum blood pressure and the maximum blood pressure decrease level exceed a predetermined threshold value, and the display means 7 (notification means) determines that the maximum blood pressure or the maximum blood pressure decrease level exceeds a predetermined threshold value. On the condition that this is done, the predetermined notification according to the maximum blood pressure or the maximum blood pressure decrease level is performed, so that the abnormalities of the patient can be accurately notified by effectively utilizing the maximum blood pressure and the maximum blood pressure decrease level.

またさらに、本実施形態に係る算出手段4は、脈圧、平均血圧及び最低血圧に加え、血圧検出手段2による検出値に基づいて、脈拍数及び該脈拍数に最高血圧を乗算して求められるPRPを求めるものとされ、判定手段5にて脈拍数及びPRPが所定閾値を超えたか否か判定するとともに、表示手段7(報知手段)にて脈拍数又はPRPが所定閾値を超えたと判定されたことを条件として、当該脈拍数又はPRPに応じた所定の報知を行わせるので、脈拍数及びPRPを有効活用して患者の異常を精度よく報知することができる。   Furthermore, the calculation means 4 according to the present embodiment is obtained by multiplying the pulse rate and the pulse rate by the maximum blood pressure based on the detected value by the blood pressure detection means 2 in addition to the pulse pressure, the average blood pressure, and the minimum blood pressure. The PRP is determined, and it is determined whether or not the pulse rate and PRP have exceeded a predetermined threshold value by the determination unit 5, and it is determined by the display unit 7 (notification unit) that the pulse rate or PRP has exceeded the predetermined threshold value. Since the predetermined notification according to the pulse rate or PRP is performed on the condition, the patient's abnormality can be notified with high accuracy by effectively using the pulse rate and PRP.

特に、本実施形態に係る報知手段は、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段7から成り、当該表示手段7によって、算出手段4で求められた算出値と血液浄化治療中の循環血液量の変化率とが併せて表示されるので、循環血液量の変化率と算出手段で求められた算出値とを関連させて監視することができる。なお、本実施形態においては、報知手段が表示手段7にて構成されているが、他の手段(スピーカや別途設けられたモニタ等)であってもよい。   In particular, the notifying unit according to the present embodiment includes a display unit 7 that can display information related to blood purification treatment in real time, and the display unit 7 calculates the calculated value obtained by the calculation unit 4 and the blood purification treatment in progress. Since the change rate of the circulating blood volume is displayed together, it is possible to monitor the change rate of the circulating blood volume in association with the calculated value obtained by the calculating means. In the present embodiment, the notification means is constituted by the display means 7, but other means (speaker, monitor provided separately, etc.) may be used.

次に、本発明に係る第2の実施形態について説明する。
本実施形態に係る血液浄化装置は、図6に示すように、治療手段1と、血圧検出手段2と、入力手段3と、算出手段4と、判定手段5と、制御手段6と、表示手段7(本発明の「報知手段」に相当)とを主に有するとともに、心電図用測定手段14と、入力手段15と、心電図取得手段16と、解析手段17と、出力手段18とを有して構成されている。なお、本実施形態においては、透析装置本体Hとは別個の外部情報処理装置Lに入力手段15、心電図取得手段16、解析手段17及び出力手段18が配設されている。また、第1の実施形態と同様の構成要素には、同一の符号を付し、それらの詳細な説明を省略する。
Next, a second embodiment according to the present invention will be described.
As shown in FIG. 6, the blood purification apparatus according to the present embodiment includes a treatment unit 1, a blood pressure detection unit 2, an input unit 3, a calculation unit 4, a determination unit 5, a control unit 6, and a display unit. 7 (corresponding to “notification means” of the present invention), and also includes an electrocardiogram measurement means 14, an input means 15, an electrocardiogram acquisition means 16, an analysis means 17, and an output means 18. It is configured. In the present embodiment, the input unit 15, the electrocardiogram acquisition unit 16, the analysis unit 17, and the output unit 18 are disposed in an external information processing apparatus L that is separate from the dialysis machine main body H. Moreover, the same code | symbol is attached | subjected to the component similar to 1st Embodiment, and those detailed description is abbreviate | omitted.

心電図用測定手段14は、患者の皮膚に密着して取り付けられ、その患者の心電図(生体情報)を測定し得るもので、心臓を挟んだ位置にそれぞれ密着して取り付けられる少なくとも一対の電極で構成されるとともに、入力手段15に電気的に接続されている。入力手段15は、心電図取得手段16と電気的に接続されたもので、心電図用測定手段14からの測定信号を心電図取得手段16に送信可能とされている。かかる心電図取得手段16は、心電図用測定手段14からの測定信号に基づいて、血液浄化治療中の患者の心電図をリアルタイムに得るよう構成されている。   The electrocardiogram measuring means 14 is attached in close contact with the patient's skin and can measure the electrocardiogram (biological information) of the patient, and is composed of at least a pair of electrodes that are attached in close contact with a position sandwiching the heart. And electrically connected to the input means 15. The input unit 15 is electrically connected to the electrocardiogram acquisition unit 16, and can transmit a measurement signal from the electrocardiogram measurement unit 14 to the electrocardiogram acquisition unit 16. The electrocardiogram acquisition unit 16 is configured to obtain an electrocardiogram of a patient undergoing blood purification treatment in real time based on a measurement signal from the electrocardiogram measurement unit 14.

解析手段17は、心電図取得手段16で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得るもので、後述するように、当該解析手段17による心拍変動解析の結果に応じて判定手段5による判定が行われるよう構成されている。出力手段18は、入力手段3に電気的に接続されたもので、心電図用測定手段14で取得された心電図及び解析手段17による心拍変動解析の結果等の外部情報を出力することにより、当該外部情報を入力手段3にて入力させ得るよう構成されている。なお、入力手段3と出力手段18とは、配線にて接続されるものの他、無線等で接続されていてもよい。   The analysis means 17 can evaluate the autonomic nervous function by performing heart rate variability analysis based on the electrocardiogram acquired by the electrocardiogram acquisition means 16 and, as will be described later, according to the result of the heart rate variability analysis by the analysis means 17. The determination by the determination means 5 is performed. The output means 18 is electrically connected to the input means 3 and outputs the external information such as the electrocardiogram acquired by the electrocardiogram measurement means 14 and the result of the heart rate variability analysis by the analysis means 17 to output the external information. Information is input by the input means 3. In addition, the input means 3 and the output means 18 may be connected by radio | wireless etc. other than what is connected by wiring.

ここで、本実施形態に係る血液浄化装置においては、判定手段5にて心電図取得手段16で取得された心電図に異常があるか否かを判定するとともに、心電図に異常があると判定されたことを条件として、表示手段7(報知手段)にて当該心電図の異常に応じた所定の報知を行わせるよう構成されている。また、本実施形態おいては、心電図取得手段16で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得る解析手段17を具備するとともに、当該解析手段17による心拍変動解析の結果に応じて判定手段5による判定が行われるようになっている。   Here, in the blood purification apparatus according to the present embodiment, the determination unit 5 determines whether or not the electrocardiogram acquired by the electrocardiogram acquisition unit 16 is abnormal and determines that the electrocardiogram is abnormal. As a condition, the display means 7 (notification means) is configured to perform predetermined notification according to the abnormality of the electrocardiogram. In the present embodiment, the analysis means 17 that can evaluate the autonomic nerve function by performing heart rate variability analysis based on the electrocardiogram acquired by the electrocardiogram acquisition means 16 is provided. The determination by the determination means 5 is performed according to the result.

次に、本実施形態に係る血液浄化装置における判定手段5の判定方法について、図7のフローチャートに基づいて説明する。
まず、心電図用測定手段14で得られた心電図に基づいたST測定値が正常であるか否かが判定され(S1)、当該ST値が異常であると判定されると、患者が心筋虚血状態の可能性がある旨を表示手段7にて表示して報知する(S2)とともに、正常であると判定されると、S2をスキップしてS3に進む。なお、S2の報知により、心電図の異常により心原性ショックか否かが判定されることとなる。
Next, the determination method of the determination means 5 in the blood purification apparatus according to the present embodiment will be described based on the flowchart of FIG.
First, it is determined whether or not the ST measurement value based on the electrocardiogram obtained by the electrocardiogram measurement means 14 is normal (S1). If it is determined that the ST value is abnormal, the patient is subjected to myocardial ischemia. The display means 7 informs that there is a possibility of a state (S2), and if it is determined to be normal, skips S2 and proceeds to S3. In addition, it will be determined by the alerting | reporting of S2 whether it is a cardiogenic shock by abnormality of an electrocardiogram.

S3においては、心電図用測定手段14で得られた心電図に基づき不整脈の発生頻度が判定され、発生頻度が多いと判定されると、患者が不整脈頻発状態である旨を表示手段7にて表示して報知する(S4)とともに、発生頻度が少ないと判定されると、S9に進み、解析手段17による心拍変動解析の結果、交感神経が亢進した状態であるか、或いは副交感神経が亢進した状態であるか判定される。そして、S19にて交感神経亢進と判定されると、S20に進み、副交感神経亢進と判定されると、S22に進む。   In S3, the occurrence frequency of the arrhythmia is determined based on the electrocardiogram obtained by the electrocardiogram measurement means 14, and if it is determined that the occurrence frequency is high, the display means 7 displays that the patient is in an arrhythmia frequent state. (S4) and if it is determined that the frequency of occurrence is low, the process proceeds to S9, and as a result of the heart rate variability analysis by the analysis means 17, the sympathetic nerve is enhanced or the parasympathetic nerve is enhanced. Judgment is made. If it is determined in S19 that the sympathetic nerve is increased, the process proceeds to S20, and if it is determined that the parasympathetic nerve is increased, the process proceeds to S22.

S20においては、心拍数が所定閾値(例えば100(bpm))を超えたか否かが何低され、所定閾値を超えたと判定されると、患者が頻脈状態である旨を表示手段7にて表示して報知する(S21)とともに、所定閾値を超えないと判定されると、S21をスキップしてS5に進む。また、S22においては、心拍数が所定閾値(S20で判定される所定閾値より低い値であって、例えば50(bpm))を超えたか否かが判定され、所定閾値を超えない場合、S23にて患者が徐脈状態である旨を表示手段7にて表示して報知した後、一連の制御を終了させる。なお、S22にて心拍数が所定閾値を超えたと判定されると、S7に進むこととなる。   In S20, the display means 7 indicates that the heart rate has exceeded a predetermined threshold (for example, 100 (bpm)) and if it is determined that the heart rate has exceeded the predetermined threshold, the display means 7 indicates that the patient is in a tachycardia state. When the information is displayed and notified (S21) and it is determined that the predetermined threshold is not exceeded, S21 is skipped and the process proceeds to S5. In S22, it is determined whether or not the heart rate has exceeded a predetermined threshold (a value lower than the predetermined threshold determined in S20, for example, 50 (bpm)). After the display means 7 displays and informs that the patient is in a bradycardia state, a series of controls are terminated. If it is determined in S22 that the heart rate has exceeded the predetermined threshold value, the process proceeds to S7.

一方、算出手段4で算出されたPRPが所定閾値(例えば12000)を超えたか否かが判定され(S5)、所定閾値を超えたと判定されると、患者が心筋虚血状態の可能性がある旨を表示手段7にて表示して報知する(S6)。なお、PRPが所定閾値を超えない場合、S6をスキップしてS7に進む。   On the other hand, it is determined whether or not the PRP calculated by the calculation means 4 exceeds a predetermined threshold (for example, 12000) (S5). If it is determined that the PRP exceeds the predetermined threshold, the patient may have a myocardial ischemia state. A message to that effect is displayed on the display means 7 (S6). If PRP does not exceed the predetermined threshold, S6 is skipped and the process proceeds to S7.

S7においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最高血圧が所定閾値(例えば90(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者の最高血圧が低下した状態である旨を表示手段7にて表示して報知する(S8)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S8をスキップしてS9に進む。   In S7, it is determined whether or not the maximum blood pressure calculated by the calculation unit 4 based on the detection value of the blood pressure detection unit 2 exceeds a predetermined threshold (for example, 90 (mmHg)), and exceeds the predetermined threshold (in this case) If it is determined that the patient's systolic blood pressure has fallen, the display means 7 displays and notifies the display means 7 (S8), and the predetermined value is not exceeded (in this case, the predetermined value is not exceeded). If it is determined that the threshold value has been exceeded, the process skips S8 and proceeds to S9.

S9においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最高血圧低下度が所定閾値(例えば30(mmHg))を超えたか否かが判定され、所定閾値を超えたと判定されると、患者の最高血圧低下度を表示手段7にて表示して報知する(S10)とともに、所定値を超えないと判定されると、S10をスキップしてS11に進む。   In S9, it is determined whether or not the maximum blood pressure reduction degree calculated by the calculation unit 4 based on the detection value of the blood pressure detection unit 2 exceeds a predetermined threshold (for example, 30 (mmHg)), and it is determined that the predetermined threshold is exceeded. Then, the patient's maximum blood pressure lowering degree is displayed and notified on the display means 7 (S10), and if it is determined that the predetermined value is not exceeded, S10 is skipped and the process proceeds to S11.

S11においては、血圧検出手段2の検出値に基づいて算出手段4で算出された脈圧(循環動態の指標)が所定閾値(例えば30(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が脈圧低下状態である旨を表示手段7にて表示して報知する(S12)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S12をスキップしてS13、S15に進む。ここで、本実施形態においては、S12にて、患者の治療中における危険度が中程度として報知するよう構成されている。   In S11, it is determined whether or not the pulse pressure (circulation dynamic index) calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 30 (mmHg)) based on the detection value of the blood pressure detection unit 2. (In this case, if it is determined that the value has fallen below the predetermined threshold value), the display means 7 displays and notifies that the patient is in a reduced pulse pressure state (S12), and does not exceed the predetermined value ( In this case, if it is determined that the predetermined threshold is exceeded, S12 is skipped and the process proceeds to S13 and S15. Here, in the present embodiment, in S12, it is configured to notify that the degree of risk during the treatment of the patient is medium.

S13においては、血圧検出手段2の検出値に基づいて算出手段4で算出された平均血圧(重要臓器の血流量の指標)が所定閾値(例えば60(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が平均血圧低下状態である旨を表示手段7にて表示して報知する(S14)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S14をスキップしてS17に進む。   In S13, it is determined whether or not the average blood pressure (index of blood flow of important organs) calculated by the calculation unit 4 exceeds a predetermined threshold (for example, 60 (mmHg)) based on the detection value of the blood pressure detection unit 2. When it is determined that the predetermined threshold value is exceeded (in this case, the predetermined threshold value is exceeded), the display means 7 displays and notifies that the patient is in an average blood pressure lowering state (S14), and the predetermined value is If it is determined that it does not exceed (in this case, a predetermined threshold value is exceeded), S14 is skipped and the process proceeds to S17.

S15においては、血圧検出手段2の検出値に基づいて算出手段4で算出された最低血圧(冠動脈血流量の指標)が所定閾値(例えば40(mmHg))を超えたか否かが判定され、所定閾値を超えた(この場合、所定閾値を下回った)と判定されると、患者が最低血圧低下状態である旨を表示手段7にて表示して報知する(S16)とともに、所定値を超えない(この場合、所定閾値を上回った)と判定されると、S16をスキップしてS17に進む。   In S15, it is determined based on the detection value of the blood pressure detection means 2 whether or not the minimum blood pressure (coronary artery blood flow index) calculated by the calculation means 4 exceeds a predetermined threshold (for example, 40 (mmHg)). If it is determined that the threshold value has been exceeded (in this case, it has fallen below the predetermined threshold value), the display means 7 displays and notifies that the patient is in the state of lowering the minimum blood pressure (S16), and the predetermined value is not exceeded. If it is determined (in this case, the value exceeds the predetermined threshold), S16 is skipped and the process proceeds to S17.

S17においては、S12による報知が行われ、且つ、S14による報知又はS16による報知が行われたか否かが判定され、S12による報知が行われ、且つ、S14による報知又はS16による報知が行われたと判定されると、S18にて患者の治療中における危険度が高い状態として報知するとともに、S12による報知が行われ、且つ、S14による報知及びS16による報知が行われない場合、S18をスキップして一連の制御が終了するよう構成されている。すなわち、脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで表示手段7(報知手段)による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせるようになっているのである。   In S17, it is determined whether the notification by S12 has been performed, whether the notification by S14 or the notification by S16 has been performed, the notification by S12 has been performed, and the notification by S14 or the notification by S16 has been performed. If determined, in S18, the patient is informed as having a high degree of risk during treatment, and if S12 is notified, and if S14 and S16 are not performed, S18 is skipped. A series of controls are configured to end. That is, the first state in which the pulse pressure exceeds a predetermined threshold and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold, and at least one of the minimum blood pressure and the average blood pressure is predetermined. The notification form regarding the degree of risk by the display means 7 (notification means) is different from that in the second state exceeding the threshold value, and the second state is notified that the degree of risk is higher than the first state. It is like that.

上記実施形態によれば、第1の実施形態の効果の他、血液浄化治療中の患者の心電図を測定し得る心電図用測定手段14と、該心電図用測定手段14からの測定信号に基づいて心電図を得る心電図取得手段16とを具備するとともに、判定手段5にて心電図取得手段16で取得された心電図に異常があるか否かを判定するとともに、心電図に異常があると判定されたことを条件として、表示手段7(報知手段)にて当該心電図の異常に応じた所定の報知を行わせるので、血圧に関するパラメータに加え、心電図取得手段16で取得された心電図を活用して患者の異常をより精度よく報知することができる。   According to the above embodiment, in addition to the effects of the first embodiment, the electrocardiogram measuring means 14 capable of measuring the electrocardiogram of the patient undergoing blood purification treatment, and the electrocardiogram based on the measurement signal from the electrocardiogram measuring means 14 And an electrocardiogram acquisition means 16 for obtaining the condition, and the determination means 5 determines whether or not the electrocardiogram acquired by the electrocardiogram acquisition means 16 is abnormal and determines that the electrocardiogram is abnormal. Since the display means 7 (notification means) performs predetermined notification according to the abnormality of the electrocardiogram, in addition to the parameters relating to blood pressure, the electrocardiogram acquired by the electrocardiogram acquisition means 16 is utilized to further prevent the abnormality of the patient. Information can be accurately reported.

また、本実施形態によれば、心電図取得手段16で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得る解析手段17を具備するとともに、当該解析手段17による心拍変動解析の結果に応じて判定手段5による判定が行われるので、自律神経機能を勘案した判定を行わせることができる。なお、解析手段17による解析を行わず、専ら心電図取得手段16で取得した心電図の情報を出力手段18及び入力手段3を介して算出手段4、判定手段5等に送信するようにしてもよい。   Further, according to the present embodiment, the analysis unit 17 that can evaluate the autonomic nerve function by performing the heart rate variability analysis based on the electrocardiogram acquired by the electrocardiogram acquisition unit 16 is provided. Since the determination by the determination means 5 is performed according to the result, it is possible to make a determination in consideration of the autonomic nerve function. Instead of performing the analysis by the analysis unit 17, the electrocardiogram information acquired exclusively by the electrocardiogram acquisition unit 16 may be transmitted to the calculation unit 4, the determination unit 5, etc. via the output unit 18 and the input unit 3.

さらに、外部情報処理装置Lは、血液浄化装置に血液浄化治療に関わる条件又は情報を送信し得る中央監視装置、又は血液浄化治療中の患者の近傍に配設されたベッドサイド端末装置(例えば、ベッドサイドモニタ等)から成るものとしてもよい。外部情報処理装置Lを中央監視装置又はベッドサイド端末装置とした場合、従来の血液浄化装置が具備するベッドサイド端末装置又は中央監視装置を流用することができる。   Furthermore, the external information processing device L is a central monitoring device that can transmit conditions or information related to blood purification treatment to the blood purification device, or a bedside terminal device (for example, Or a bedside monitor). When the external information processing device L is a central monitoring device or a bedside terminal device, the bedside terminal device or the central monitoring device provided in the conventional blood purification device can be used.

以上、本実施形態について説明したが、本発明はこれに限定されず、例えば算出手段4で算出されるとともに判定手段5で判定される血圧に関するパラメータは、少なくとも脈圧、平均血圧及び最低血圧であれば足り、他のパラメータに関しては任意のものとすることができる。特に、第2の実施形態における入力手段15、心電図取得手段16、解析手段17及び出力手段18を透析装置本体Hに備えるものとし、外部情報処理装置Lを経由しないものとしてもよい。   Although the present embodiment has been described above, the present invention is not limited to this. For example, the blood pressure parameters calculated by the calculation unit 4 and determined by the determination unit 5 are at least pulse pressure, average blood pressure, and minimum blood pressure. Any other parameters are sufficient, and any other parameters can be used. In particular, the input unit 15, the electrocardiogram acquisition unit 16, the analysis unit 17, and the output unit 18 in the second embodiment may be provided in the dialyzer main body H and may not pass through the external information processing apparatus L.

また、報知手段(本実施形態においては表示手段7)は、算出手段4で算出された算出値に基づいて推定される患者の状態を表示し得るものとしてもよく、例えば脈圧が所定閾値を超えた場合、「循環血液量又は心拍出量の低下」なる表示、平均血圧が所定閾値を超えた場合、「重要臓器への血流量低下」なる表示、最低血圧が所定閾値を超えた場合、「冠動脈血流量の低下」「血圧が維持できない虞がある」なる表示等を行って報知してもよい。このように、算出手段4で算出された算出値に基づいて推定される患者の状態を表示手段7(報知手段)にて表示するようにすれば、算出手段4で算出された算出値を単に表示させるものに比べ、医師等医療従事者に対して患者の状態をより容易に把握させることができる。   Further, the notification means (display means 7 in the present embodiment) may display the patient state estimated based on the calculated value calculated by the calculating means 4, for example, the pulse pressure has a predetermined threshold value. If it exceeds, the indication “decrease in circulating blood volume or cardiac output”, if the average blood pressure exceeds a certain threshold, if “average blood flow drops to important organ”, if the minimum blood pressure exceeds a certain threshold In addition, a display such as “decrease in coronary blood flow” or “probable blood pressure cannot be maintained” may be performed. In this way, when the patient state estimated based on the calculated value calculated by the calculating means 4 is displayed on the display means 7 (notifying means), the calculated value calculated by the calculating means 4 is simply used. Compared with what is displayed, it is possible to make it easier for medical personnel such as doctors to grasp the patient's condition.

さらに、報知手段による報知に加え、治療手段1による所定の動作を停止(例えば、脈圧が所定閾値を超えた場合、除水ポンプ13を停止させる等)させるようにしてもよい。なお、本実施形態に係る血液浄化装置は、血液透析治療を行うための血液透析装置に適用されているが、他の形態の血液浄化治療を行うための血液浄化装置であってもよい。   Furthermore, in addition to the notification by the notification unit, the predetermined operation by the treatment unit 1 may be stopped (for example, when the pulse pressure exceeds a predetermined threshold value, the water removal pump 13 is stopped). The blood purification apparatus according to this embodiment is applied to a hemodialysis apparatus for performing hemodialysis treatment, but may be a blood purification apparatus for performing other forms of blood purification treatment.

血圧検出手段による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求める算出手段と、該算出手段で求められた脈圧、平均血圧及び最低血圧がそれぞれ所定閾値を超えたか否か判定する判定手段と、該判定手段にて脈圧、最低血圧又は平均血圧が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧に応じた所定の報知を行わせる報知手段とを備えた血液浄化装置であれば、外観形状が異なるもの或いは他の機能が付加されたもの等にも適用することができる。   Based on detection values by the blood pressure detection means, calculation means for obtaining at least pulse pressure, average blood pressure, and minimum blood pressure, and whether or not the pulse pressure, average blood pressure, and minimum blood pressure determined by the calculation means have exceeded predetermined threshold values, respectively And a predetermined notification according to the pulse pressure, the minimum blood pressure, or the average blood pressure, provided that the determination means determines that the pulse pressure, the minimum blood pressure, or the average blood pressure exceeds a predetermined threshold. If it is a blood purification apparatus provided with an alerting | reporting means, it can apply also to the thing from which an external shape differs, or the thing to which the other function was added.

1 治療手段
2 血圧検出手段
3 入力手段
4 算出手段
5 判定手段
6 制御手段
7 表示手段
8 血液回路
9 ダイアライザ(血液浄化手段)
10 血液ポンプ
11 エアトラップチャンバ
12 ヘマトクリットセンサ
13 除水ポンプ
14 心電図用測定手段
15 入力手段
16 心電図取得手段
17 解析手段
18 出力手段
DESCRIPTION OF SYMBOLS 1 Treatment means 2 Blood pressure detection means 3 Input means 4 Calculation means 5 Judgment means 6 Control means 7 Display means 8 Blood circuit 9 Dialyzer (blood purification means)
DESCRIPTION OF SYMBOLS 10 Blood pump 11 Air trap chamber 12 Hematocrit sensor 13 Water removal pump 14 Electrocardiogram measurement means 15 Input means 16 Electrocardiogram acquisition means 17 Analysis means 18 Output means

Claims (9)

体外循環する患者の血液を浄化して血液浄化治療を行い得る治療手段と、
血液浄化治療中の患者の血圧及び脈拍を検出し得る血圧検出手段と、
を備えた血液浄化装置において、
前記血圧検出手段による検出値に基づいて、少なくとも脈圧、平均血圧及び最低血圧を求める算出手段と、
該算出手段で求められた前記脈圧、平均血圧及び最低血圧がそれぞれ所定閾値を超えたか否か判定する判定手段と、
該判定手段にて前記脈圧、最低血圧又は平均血圧が所定閾値を超えたと判定されたことを条件として、当該脈圧、最低血圧又は平均血圧に応じた所定の報知を行わせる報知手段と、
を備えたことを特徴とする血液浄化装置。
A therapeutic means capable of purifying the blood of a patient circulating outside the body and performing blood purification treatment;
Blood pressure detection means capable of detecting the blood pressure and pulse of a patient undergoing blood purification treatment;
In the blood purification apparatus comprising
Calculation means for obtaining at least a pulse pressure, an average blood pressure and a minimum blood pressure based on a detection value by the blood pressure detection means;
Determining means for determining whether or not the pulse pressure, mean blood pressure and minimum blood pressure determined by the calculating means each exceed a predetermined threshold;
Notification means for performing predetermined notification according to the pulse pressure, minimum blood pressure, or average blood pressure on condition that the determination means determines that the pulse pressure, minimum blood pressure, or average blood pressure exceeds a predetermined threshold;
A blood purification apparatus comprising:
前記脈圧が所定閾値を超え、且つ、前記最低血圧及び平均血圧が所定閾値を超えない第1の状態と、当該脈圧が所定閾値を超え、且つ、最低血圧及び平均血圧の少なくとも一方が所定閾値を超えた第2の状態とで前記報知手段による危険度に関する報知形態を異ならせ、当該第2の状態の方が第1の状態より危険度が高い旨の報知を行わせることを特徴とする請求項1記載の血液浄化装置。   A first state in which the pulse pressure exceeds a predetermined threshold and the minimum blood pressure and the average blood pressure do not exceed the predetermined threshold; and the pulse pressure exceeds a predetermined threshold and at least one of the minimum blood pressure and the average blood pressure is predetermined The notification form regarding the degree of risk by the notification means is different from that in the second state exceeding the threshold, and notification that the degree of risk is higher in the second state than in the first state is provided. The blood purification apparatus according to claim 1. 前記算出手段は、前記脈圧、平均血圧及び最低血圧に加え、前記血圧検出手段による検出値に基づいて、最高血圧及び血液浄化治療開始からの最高血圧低下度を求めるものとされ、前記判定手段にて前記最高血圧及び最高血圧低下度が所定閾値を超えたか否か判定するとともに、前記報知手段にて前記最高血圧又は最高血圧低下度が所定閾値を超えたと判定されたことを条件として、当該最高血圧又は最高血圧低下度に応じた所定の報知を行わせることを特徴とする請求項1又は請求項2記載の血液浄化装置。   The calculating means obtains the maximum blood pressure and the maximum blood pressure decrease degree from the start of blood purification treatment based on the detected value by the blood pressure detecting means in addition to the pulse pressure, the average blood pressure and the minimum blood pressure, and the determining means And whether or not the systolic blood pressure and the systolic blood pressure lowering degree exceed a predetermined threshold, and on the condition that the notifying means determines that the systolic blood pressure or the systolic blood pressure lowering degree exceeds a predetermined threshold, The blood purification apparatus according to claim 1 or 2, wherein a predetermined notification according to the maximum blood pressure or the maximum blood pressure lowering level is performed. 前記算出手段は、前記脈圧、平均血圧及び最低血圧に加え、前記血圧検出手段による検出値に基づいて、脈拍数及び該脈拍数に最高血圧を乗算して求められるPRPを求めるものとされ、前記判定手段にて前記脈拍数及びPRPが所定閾値を超えたか否か判定するとともに、前記報知手段にて前記脈拍数又はPRPが所定閾値を超えたと判定されたことを条件として、当該脈拍数又はPRPに応じた所定の報知を行わせることを特徴とする請求項1〜3の何れか1つに記載の血液浄化装置。   The calculation means obtains a pulse rate and a PRP obtained by multiplying the pulse rate by the maximum blood pressure based on a detection value by the blood pressure detection means in addition to the pulse pressure, the average blood pressure, and the minimum blood pressure, The determination means determines whether the pulse rate and PRP have exceeded a predetermined threshold, and the pulse rate or PRP is determined on the condition that the notification means determines that the pulse rate or PRP has exceeded a predetermined threshold. The blood purification apparatus according to any one of claims 1 to 3, wherein a predetermined notification according to PRP is performed. 前記報知手段は、血液浄化治療に関わる情報をリアルタイムに表示させ得る表示手段から成り、当該表示手段によって、前記算出手段で求められた算出値と血液浄化治療中の循環血液量の変化率とが併せて表示されることを特徴とする請求項1〜4の何れか1つに記載の血液浄化装置。   The notification means includes display means capable of displaying information related to blood purification treatment in real time, and the display means provides a calculated value obtained by the calculation means and a rate of change in circulating blood volume during blood purification treatment. The blood purification apparatus according to any one of claims 1 to 4, wherein the blood purification apparatus is displayed together. 血液浄化治療中の患者の心電図を測定し得る心電図用測定手段と、
該心電図用測定手段からの測定信号に基づいて心電図を得る心電図取得手段と、
を具備するとともに、前記判定手段にて前記心電図取得手段で取得された心電図に異常があるか否かを判定するとともに、前記心電図に異常があると判定されたことを条件として、前記報知手段にて当該心電図の異常に応じた所定の報知を行わせることを特徴とする請求項1〜5の何れか1つに記載の血液浄化装置。
An electrocardiogram measuring means capable of measuring an electrocardiogram of a patient undergoing blood purification treatment;
An electrocardiogram acquisition means for obtaining an electrocardiogram based on a measurement signal from the electrocardiogram measurement means;
And determining whether or not there is an abnormality in the electrocardiogram acquired by the electrocardiogram acquisition means and determining that the electrocardiogram is abnormal in the determination means. The blood purification apparatus according to any one of claims 1 to 5, wherein predetermined notification according to abnormality of the electrocardiogram is performed.
前記心電図取得手段で取得された心電図に基づき心拍変動解析を行って自律神経機能を評価し得る解析手段を具備するとともに、当該解析手段による心拍変動解析の結果に応じて前記判定手段による判定が行われることを特徴とする請求項6記載の血液浄化装置。   Analyzing means capable of performing heart rate variability analysis based on the electrocardiogram acquired by the electrocardiogram acquiring means and evaluating the autonomic nervous function, and determining by the determining means according to a result of the heart rate variability analysis by the analyzing means. The blood purification apparatus according to claim 6, wherein 前記心電図取得手段及び解析手段は、血液浄化治療中の患者の近傍に配設されたベッドサイド端末装置、又は血液浄化治療に関わる条件又は情報を送信し得る中央監視装置に配設されたことを特徴とする請求項7記載の血液浄化装置。   The electrocardiogram acquisition means and the analysis means are disposed in a bedside terminal device disposed in the vicinity of a patient undergoing blood purification treatment, or a central monitoring device capable of transmitting conditions or information relating to blood purification treatment. 8. The blood purification apparatus according to claim 7, wherein 前記報知手段は、前記算出手段で算出された算出値に基づいて推定される患者の状態を表示し得ることを特徴とする請求項1〜8の何れか1つに記載の血液浄化装置。   The blood purification apparatus according to any one of claims 1 to 8, wherein the notifying means can display a state of a patient estimated based on the calculated value calculated by the calculating means.
JP2015100155A 2015-05-15 2015-05-15 Blood purification equipment Active JP6496606B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015100155A JP6496606B2 (en) 2015-05-15 2015-05-15 Blood purification equipment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015100155A JP6496606B2 (en) 2015-05-15 2015-05-15 Blood purification equipment

Publications (2)

Publication Number Publication Date
JP2016214367A true JP2016214367A (en) 2016-12-22
JP6496606B2 JP6496606B2 (en) 2019-04-03

Family

ID=57578900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015100155A Active JP6496606B2 (en) 2015-05-15 2015-05-15 Blood purification equipment

Country Status (1)

Country Link
JP (1) JP6496606B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019078273A1 (en) * 2017-10-17 2019-04-25 日機装株式会社 Blood purification device
US10345175B2 (en) 2011-05-31 2019-07-09 Nxstage Medical, Inc. Pressure measurement devices, methods, and systems
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10864312B2 (en) 2005-11-09 2020-12-15 B. Braun Medical Inc. Diaphragm pressure pod for medical fluids
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101893A (en) * 1977-02-18 1978-09-05 Iriyou Kougaku Kenkiyuushiyo K Device for supervising artificial dialysis
JPS6092769A (en) * 1983-10-27 1985-05-24 株式会社メデクス Apparatus for treating blood in outside of living body
JP2004248793A (en) * 2003-02-19 2004-09-09 Philips Japan Ltd Bedside information system
JP2007143815A (en) * 2005-11-28 2007-06-14 Nikkiso Co Ltd Blood purifying apparatus, and blood purifying method
JP2008512177A (en) * 2004-09-13 2008-04-24 ガンブロ・ルンディア・エービー Detection of rapid changes in blood pressure

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101893A (en) * 1977-02-18 1978-09-05 Iriyou Kougaku Kenkiyuushiyo K Device for supervising artificial dialysis
JPS6092769A (en) * 1983-10-27 1985-05-24 株式会社メデクス Apparatus for treating blood in outside of living body
JP2004248793A (en) * 2003-02-19 2004-09-09 Philips Japan Ltd Bedside information system
JP2008512177A (en) * 2004-09-13 2008-04-24 ガンブロ・ルンディア・エービー Detection of rapid changes in blood pressure
JP2007143815A (en) * 2005-11-28 2007-06-14 Nikkiso Co Ltd Blood purifying apparatus, and blood purifying method

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10864312B2 (en) 2005-11-09 2020-12-15 B. Braun Medical Inc. Diaphragm pressure pod for medical fluids
US11529448B2 (en) 2011-05-31 2022-12-20 Nxstage Medical, Inc. Pressure measurement devices, methods, and systems
US10345175B2 (en) 2011-05-31 2019-07-09 Nxstage Medical, Inc. Pressure measurement devices, methods, and systems
US10835657B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11850341B2 (en) 2014-10-10 2023-12-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10835658B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11406744B2 (en) 2014-10-10 2022-08-09 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10835659B2 (en) 2014-10-10 2020-11-17 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10869958B2 (en) 2014-10-10 2020-12-22 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11607482B2 (en) 2016-07-18 2023-03-21 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
CN111225694A (en) * 2017-10-17 2020-06-02 日机装株式会社 Blood purification device
CN111225694B (en) * 2017-10-17 2022-07-08 日机装株式会社 Blood purification device
JP6997582B2 (en) 2017-10-17 2022-01-17 日機装株式会社 Blood purification device
US11179507B2 (en) 2017-10-17 2021-11-23 Nikkiso Company Limited Blood purification apparatus
WO2019078273A1 (en) * 2017-10-17 2019-04-25 日機装株式会社 Blood purification device
JP2019072282A (en) * 2017-10-17 2019-05-16 日機装株式会社 Blood purification device

Also Published As

Publication number Publication date
JP6496606B2 (en) 2019-04-03

Similar Documents

Publication Publication Date Title
JP6496606B2 (en) Blood purification equipment
JP4822258B2 (en) Hemodialysis machine
JP2019150651A (en) Monitoring body fluid volume for patients with renal disease
JP5158830B2 (en) Dialysis treatment device
US6878272B2 (en) Dialyzing apparatus
JP2014518688A5 (en)
US10518018B2 (en) Blood purification system
JP6716428B2 (en) Blood purification treatment support system
JP2010063644A (en) Blood purifying apparatus
JP2006280961A (en) Method to monitor autonomic nerve activity
JP4393789B2 (en) Autonomic nerve activity monitoring device
JPWO2019017212A1 (en) Blood purification device
US6878273B2 (en) Dialyzing apparatus
JP6778097B2 (en) Exercise support device
JP6708539B2 (en) Exercise support device
JP6873797B2 (en) Blood purification device
CN109996574B (en) Exercise support device
JP2010068927A (en) Blood purifying apparatus

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180129

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181019

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190221

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190311

R150 Certificate of patent or registration of utility model

Ref document number: 6496606

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250